Literature DB >> 9737144

The influence of decisions made by developers on health status questionnaire content.

C J O'Leary1, P W Jones.   

Abstract

To investigate the effect of stringent and lenient criteria upon the process of item selection in the development of a health status questionnaire, an item pool (179 items) was administered to 139 patients with left ventricular dysfunction. Associations between each item and the criteria of gender, age, duration of disease, global health and global impairment were examined. Items were selected from the pool on the basis of their associations with the criteria using four levels of stringency. The most stringent criteria rejected items which had a shared variance of > or = 4% with gender, age and duration of disease and a shared variance of > or = 6% with global health and impairment. The most lenient criteria rejected items which had a shared variance of > or = 6% with gender, age and duration of disease and a shared variance of > or = 4% with global health and impairment. Using the most stringent criteria, 75 items were selected, compared with 127 items using the most lenient criteria. Small differences in the level of association had large effects on item selection. The choice of level of association used to base item selection can have a crucial influence on questionnaire content.

Entities:  

Mesh:

Year:  1998        PMID: 9737144     DOI: 10.1023/a:1008882626075

Source DB:  PubMed          Journal:  Qual Life Res        ISSN: 0962-9343            Impact factor:   4.147


  22 in total

1.  The measurement of health-related quality of life: major dimensions identified by factor analysis.

Authors:  C D Jenkins; R T Jono; B A Stanton; C A Stroup-Benham
Journal:  Soc Sci Med       Date:  1990       Impact factor: 4.634

2.  Measuring disease-specific quality of life in clinical trials.

Authors:  G H Guyatt; C Bombardier; P X Tugwell
Journal:  CMAJ       Date:  1986-04-15       Impact factor: 8.262

3.  Evaluation by patients with heart failure of the effects of enalapril compared with hydralazine plus isosorbide dinitrate on quality of life. V-HeFT II. The V-HeFT VA Cooperative Studies Group.

Authors:  T S Rector; G Johnson; W B Dunkman; G Daniels; L Farrell; A Henrick; B Smith; J N Cohn
Journal:  Circulation       Date:  1993-06       Impact factor: 29.690

4.  Changes in dyspnea-fatigue ratings as indicators of quality of life in the treatment of congestive heart failure.

Authors:  A R Feinstein; M B Fisher; J G Pigeon
Journal:  Am J Cardiol       Date:  1989-07-01       Impact factor: 2.778

5.  Development and testing of a new measure of health status for clinical trials in heart failure.

Authors:  G H Guyatt; S Nogradi; S Halcrow; J Singer; M J Sullivan; E L Fallen
Journal:  J Gen Intern Med       Date:  1989 Mar-Apr       Impact factor: 5.128

6.  Cardiac failure: symptoms and functional status.

Authors:  R Mayou; R Blackwood; B Bryant; J Garnham
Journal:  J Psychosom Res       Date:  1991       Impact factor: 3.006

7.  Pitfalls in the serial assessment of cardiac functional status. How a reduction in "ordinary" activity may reduce the apparent degree of cardiac compromise and give a misleading impression of improvement.

Authors:  L Goldman; E F Cook; N Mitchell; M Flatley; H Sherman; P F Cohn
Journal:  J Chronic Dis       Date:  1982

8.  Analysis of quality of life data from a randomized, placebo-controlled heart-failure trial.

Authors:  P K Tandon; H Stander; R P Schwarz
Journal:  J Clin Epidemiol       Date:  1989       Impact factor: 6.437

Review 9.  Improving patient care: some unresolved issues in heart failure.

Authors:  H Pouleur
Journal:  Cardiology       Date:  1994       Impact factor: 1.869

10.  Epidemiology of congestive heart failure.

Authors:  W M Smith
Journal:  Am J Cardiol       Date:  1985-01-11       Impact factor: 2.778

View more
  6 in total

1.  Adjusting distributions of the Health Utilities Index Mark 3 utility scores of health-related quality of life.

Authors:  Jian Sun
Journal:  Qual Life Res       Date:  2003-02       Impact factor: 4.147

2.  The left ventricular dysfunction questionnaire (LVD-36): reliability, validity, and responsiveness.

Authors:  C J O'Leary; P W Jones
Journal:  Heart       Date:  2000-06       Impact factor: 5.994

3.  Quantification of dyspnoea using descriptors: development and initial testing of the Dyspnoea-12.

Authors:  J Yorke; S H Moosavi; C Shuldham; P W Jones
Journal:  Thorax       Date:  2009-12-08       Impact factor: 9.139

4.  Examining fatigue in COPD: development, validity and reliability of a modified version of FACIT-F scale.

Authors:  Khaled Al-shair; Hana Muellerova; Janelle Yorke; Stephen I Rennard; Emiel F M Wouters; Nicola A Hanania; Amir Sharafkhaneh; Jørgen Vestbo
Journal:  Health Qual Life Outcomes       Date:  2012-08-23       Impact factor: 3.186

5.  emPHasis-10: development of a health-related quality of life measure in pulmonary hypertension.

Authors:  Janelle Yorke; Paul Corris; Sean Gaine; J Simon R Gibbs; David G Kiely; Carl Harries; Val Pollock; Iain Armstrong
Journal:  Eur Respir J       Date:  2013-11-14       Impact factor: 16.671

6.  A meta-analysis of four randomized clinical trials to confirm the reliability and responsiveness of the Shortness of Breath with Daily Activities (SOBDA) questionnaire in chronic obstructive pulmonary disease.

Authors:  Maggie Tabberer; Jean Brooks; Teresa Wilcox
Journal:  Health Qual Life Outcomes       Date:  2015-10-31       Impact factor: 3.186

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.